PubMed HealthSearch

PubMed · 7021889

Does intermittent mandatory ventilation accelerate weaning?

Abstract

Intermittent mandatory ventilation (IMV) was introduced to facilitate the weaning of patients from mechanical ventilation. The outcome of ventilator management in 116 patients who were treated in the first three months of 1975 was compared retrospectively with that of 135 patients who were treated in the first three months of 1976. All patients who were treated in 1975 received conventional (assisted or controlled) mechanical ventilation. In 1976, seventy-seven patients (57%) were treated with the use of IMV, and 58 (43%) were treated with the use of conventional mechanical ventilation. Sixty-five patients who were treated in 1976 with the use of IMV were matched with patients who were treated in 1975 with the use of conventional ventilation, on the basis of age, sex, race, history of pulmonary disease, smoking history, diagnosis, service, and location of therapy. The average time spent on a ventilator by the IMV patients was 145 hours, whereas the matched control patients spent 142 hours. The length of hospitalization was 36 days for the IMV patients and 30 days for the control patients. These time periods were not significantly different and indicate that IMV did not reduce the length of ventilator management.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

E N Schachter, D Tucker, G J Beck. 1981-09-11. Does intermittent mandatory ventilation accelerate weaning?. https://pubmed.ncbi.nlm.nih.gov/7021889/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Local and distributed effects of apomorphine on fronto-temporal function in acute unmedicated schizophrenia.

We used positron emission tomography (PET) to measure brain activity in healthy control subjects and unmedicated patients with schizophrenia. Subjects were scanned in the context of a combined psychological and pharmacological challenge, and we examined the effects of apomorphine, a drug acting on dopamine receptors, on brain systems engaged by a paced verbal fluency task. This factorial design enabled comparison of control subjects and schizophrenics in terms of the activations engendered by the cognitive task and the pharmacological challenge and the interaction of the two. We report a failure of cognitive task-related activation in anterior cingulate cortex and of task-related deactivation in the left superior temporal gyrus in the schizophrenic subjects. Compared with controls, the impaired cingulate activation was significantly reversed by apomorphine. Additionally, there was a trend for the abnormal fronto-temporal pattern of activation in schizophrenic subjects to be normalized by the drug. Overall, in schizophrenic subjects the effect of apomorphine, which we interpret in terms of a net dopaminergic antagonism, was to modify the brain activity, making the pattern more akin to that seen in control subjects. The results indicate both a regionally specific abnormality of brain function in schizophrenia and an abnormal pattern of fronto-temporal interactions.

Acute Disease